These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29872466)

  • 21. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
    Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review.
    Maniadakis N; Konstantakopoulou E
    Pharmacoeconomics; 2019 Aug; 37(8):995-1010. PubMed ID: 31012025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.
    Nicholson L; Patrao NV; Ramu J; Vazquez-Alfageme C; Muwas M; Rajendram R; Hykin PG; Sivaprasad S
    Eye (Lond); 2017 Sep; 31(9):1358-1364. PubMed ID: 28452992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Parravano M; Menchini F; Virgili G
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of navigated panretinal photocoagulation in proliferative diabetic retinopathy.
    Chhablani J; Sambhana S; Mathai A; Gupta V; Arevalo JF; Kozak I
    Am J Ophthalmol; 2015 May; 159(5):884-9. PubMed ID: 25703478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).
    Heng LZ; Sivaprasad S; Crosby-Nwaobi R; Saihan Z; Karampelas M; Bunce C; Peto T; Hykin PG
    Br J Ophthalmol; 2016 Jun; 100(6):802-7. PubMed ID: 26472406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation.
    Kim NR; Kim YJ; Chin HS; Moon YS
    Br J Ophthalmol; 2009 Jul; 93(7):901-5. PubMed ID: 19254904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiopathy and the eye].
    Rencová E
    Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders.
    Muqit MM; Sanghvi C; McLauchlan R; Delgado C; Young LB; Charles SJ; Marcellino GR; Stanga PE
    Acta Ophthalmol; 2012 Mar; 90(2):155-61. PubMed ID: 20163363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.
    Mikhail M; Stewart S; Seow F; Hogg R; Lois N
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1411-1418. PubMed ID: 29779188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?
    Blindbaek SL; Peto T; Grauslund J
    Acta Ophthalmol; 2019 Jun; 97(4):339-346. PubMed ID: 30575304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result.
    Lip PL; Cikatricis P; Sarmad A; Damato EM; Chavan R; Mitra A; Elsherbiny S; Yang Y; Mushtaq B
    Eye (Lond); 2018 Mar; 32(3):537-545. PubMed ID: 29099501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of sight-threatening diabetic retinopathy].
    Grauslund J
    Ugeskr Laeger; 2018 Jul; 180(31):. PubMed ID: 30064622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
    Wu L; Acón D; Wu A; Wu M
    Taiwan J Ophthalmol; 2019; 9(4):216-223. PubMed ID: 31942426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranibizumab and diabetic macular oedema: after laser therapy.
    Prescrire Int; 2012 Mar; 21(125):66. PubMed ID: 22428185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of therapies for diabetic macular oedema and rationale for combination therapy.
    Amoaku WM; Saker S; Stewart EA
    Eye (Lond); 2015 Sep; 29(9):1115-30. PubMed ID: 26113500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic Macular Oedema Guidelines: An Australian Perspective.
    Yuen YS; Gilhotra JS; Dalton M; Aujla JS; Mehta H; Wickremasinghe S; Uppal G; Arnold J; Chen F; Chang A; Fraser-Bell S; Lim L; Shah J; Bowditch E; Broadhead GK
    J Ophthalmol; 2023; 2023():6329819. PubMed ID: 36824442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laser Treatment for Diabetic Retinopathy: History, Mechanism, and Novel Technologies.
    Wang S; Hua R; Zhao Y; Liu L
    J Clin Med; 2024 Sep; 13(18):. PubMed ID: 39336925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.